AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography

NCT ID: NCT07144189

Last Updated: 2025-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-20

Study Completion Date

2026-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effectiveness of an artificial intelligence (AI) model developed by the investigators for identifying severe low-gradient aortic valve stenosis. Accurate assessment of stenosis severity is crucial for proper qualification for surgical treatment. It is expected that the use of AI will improve diagnostic accuracy and thereby support better clinical outcomes.

Patients with suspected significant low-gradient aortic stenosis will be enrolled. The study is observational and involves no additional risk for participants. Standard imaging studies performed for clinical indications will be additionally analyzed by the AI model, which will classify aortic stenosis as severe or moderate. The model's results will not influence the clinical management of participants but will be compared with physicians' assessments to validate its diagnostic performance.

The study will be conducted in 2025-2026. The findings will provide insights into the usefulness of AI in the diagnosis of severe aortic stenosis and may contribute to the development of advanced clinical decision-support tools.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a prospective multicenter observational validation of an artificial intelligence (AI) model for differentiating severe low-gradient from moderate aortic stenosis using transthoracic echocardiography images. The model, developed and published by the investigators, demonstrated promising diagnostic performance in retrospective data. In the present trial, approximately 300 participants with suspected significant low-gradient aortic stenosis will be enrolled during 2025-2026. Standard imaging studies performed for clinical indications will be analyzed by the AI model, which will classify aortic stenosis as severe or moderate. The AI-derived results will not influence clinical decision-making but will be compared with physicians assessments to evaluate diagnostic accuracy and reproducibility in real-world practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low-gradient Aortic Stenosis Aortic Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with suspected significant low-gradient aortic stenosis.

Approximately 300 patients with suspected significant low-gradient aortic stenosis undergoing standard echocardiographic evaluation between 2025 and 2026. Echocardiographic images will be secondarily analyzed by the AI model to classify stenosis as severe or moderate. The AI results will be compared with physicians assessments. No intervention or modification of clinical care is involved.

AI diagnostic test for severe low-gradient aortic stenosis

Intervention Type DIAGNOSTIC_TEST

All participants will undergo standard transthoracic echocardiography performed for clinical indications. Echocardiographic images will be analyzed both by experienced physicians and by the investigational AI model. Additional diagnostic tests (such as cardiac CT, low-dose dobutamine stress echocardiography or transesophageal echocardiography) may be performed if clinically indicated, according to current guideline recommendations. The AI-derived results will not influence clinical decision-making.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AI diagnostic test for severe low-gradient aortic stenosis

All participants will undergo standard transthoracic echocardiography performed for clinical indications. Echocardiographic images will be analyzed both by experienced physicians and by the investigational AI model. Additional diagnostic tests (such as cardiac CT, low-dose dobutamine stress echocardiography or transesophageal echocardiography) may be performed if clinically indicated, according to current guideline recommendations. The AI-derived results will not influence clinical decision-making.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Clinical suspicion of significant low-gradient aortic stenosis
* Echocardiographic examination performed for clinical indications
* Ability to provide informed consent

Exclusion Criteria

* Previous aortic valve intervention (surgical or transcatheter)
* Inadequate image quality precluding echocardiographic analysis
* Concomitant severe valvular disease (severe mitral stenosis or mitral/aortic regurgitation) that could confound assessment
* Patients unwilling or unable to provide informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Institute of Bioorganic Chemistry, Polish Academy of Sciences

UNKNOWN

Sponsor Role collaborator

National Institute of Cardiology, Warsaw, Poland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tomasz Hryniewiecki, Professor of Medicine

Role: STUDY_CHAIR

Department of Valvular Heart Disease, National Institute of Cardiology, Warsaw, Poland

Michał Wrzosek, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Valvular Heart Disease, National Institute of Cardiology, Warsaw, Poland

Karina Zatorska, MD, PhD

Role: STUDY_DIRECTOR

Department of Valvular Heart Disease, National Institute of Cardiology, Warsaw, Poland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Valvular Heart Disease, National Institute of Cardiology, Warsaw, Poland

Warsaw, Masovian Voivodeship, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michał Wrzosek, MD

Role: CONTACT

+48 22 3434189

Tomasz Hryniewiecki, Professor of Medicine

Role: CONTACT

+48 223434180

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michał Wrzosek, MD

Role: primary

+48516652370

References

Explore related publications, articles, or registry entries linked to this study.

Wrzosek M, Buchwald M, Czernik P, Kupinski S, Zatorska K, Jasinska A, Zakrzewski D, Pukacki J, Mazurek C, Pekal R, Hryniewiecki T. Diagnosing Severe Low-Gradient vs Moderate Aortic Stenosis with Artificial Intelligence Based on Echocardiography Images. J Imaging Inform Med. 2025 Apr 21. doi: 10.1007/s10278-025-01497-4. Online ahead of print.

Reference Type RESULT
PMID: 40259202 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4.35/VI/25

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prognostic Role of AI-Echo
NCT07009639 RECRUITING
Diagnosis of HCM With AI-ECG
NCT06287892 RECRUITING